A detailed history of Envestnet Asset Management Inc transactions in Myriad Genetics Inc stock. As of the latest transaction made, Envestnet Asset Management Inc holds 77,774 shares of MYGN stock, worth $1.71 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
77,774
Previous 67,936 14.48%
Holding current value
$1.71 Million
Previous $1.45 Million 31.35%
% of portfolio
0.0%
Previous 0.0%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 08, 2024

BUY
$17.98 - $25.47 $176,887 - $250,573
9,838 Added 14.48%
77,774 $1.9 Million
Q1 2024

May 13, 2024

SELL
$17.59 - $23.59 $2.65 Million - $3.56 Million
-150,819 Reduced 68.94%
67,936 $1.45 Million
Q4 2023

Feb 13, 2024

SELL
$13.91 - $21.32 $33,662 - $51,594
-2,420 Reduced 1.09%
218,755 $4.19 Million
Q3 2023

Nov 13, 2023

BUY
$15.99 - $23.22 $1.58 Million - $2.29 Million
98,744 Added 80.65%
221,175 $3.55 Million
Q2 2023

Aug 04, 2023

BUY
$17.56 - $23.76 $93,594 - $126,640
5,330 Added 4.55%
122,431 $2.84 Million
Q1 2023

May 11, 2023

SELL
$15.26 - $23.75 $407,762 - $634,623
-26,721 Reduced 18.58%
117,101 $2.72 Million
Q4 2022

Feb 07, 2023

SELL
$14.51 - $20.99 $152,456 - $220,541
-10,507 Reduced 6.81%
143,822 $2.09 Million
Q3 2022

Nov 10, 2022

BUY
$18.21 - $27.88 $204,461 - $313,036
11,228 Added 7.85%
154,329 $2.95 Million
Q2 2022

Aug 03, 2022

BUY
$16.45 - $25.88 $58,578 - $92,158
3,561 Added 2.55%
143,101 $2.6 Million
Q1 2022

May 04, 2022

BUY
$22.67 - $28.01 $196,548 - $242,846
8,670 Added 6.62%
139,540 $3.52 Million
Q4 2021

Feb 04, 2022

BUY
$24.13 - $32.63 $185,994 - $251,512
7,708 Added 6.26%
130,870 $3.61 Million
Q3 2021

Oct 07, 2021

BUY
$29.97 - $36.66 $357,422 - $437,207
11,926 Added 10.72%
123,162 $3.98 Million
Q2 2021

Aug 04, 2021

SELL
$25.39 - $32.61 $90,540 - $116,287
-3,566 Reduced 3.11%
111,236 $3.4 Million
Q1 2021

May 04, 2021

BUY
$19.92 - $31.6 $422,901 - $670,868
21,230 Added 22.69%
114,802 $3.5 Million
Q4 2020

Feb 02, 2021

BUY
$12.16 - $19.77 $149,312 - $242,755
12,279 Added 15.1%
93,572 $1.85 Million
Q3 2020

Oct 09, 2020

BUY
$11.25 - $14.75 $30,577 - $40,090
2,718 Added 3.46%
81,293 $1.06 Million
Q2 2020

Jul 08, 2020

BUY
$10.69 - $16.49 $229,984 - $354,765
21,514 Added 37.7%
78,575 $891,000
Q1 2020

Apr 23, 2020

BUY
$9.78 - $29.53 $349,380 - $1.05 Million
35,724 Added 167.43%
57,061 $817,000
Q4 2019

Feb 11, 2020

BUY
$20.93 - $35.1 $20,867 - $34,994
997 Added 4.9%
21,337 $581,000
Q3 2019

Oct 17, 2019

BUY
$22.08 - $47.08 $449,107 - $957,607
20,340 New
20,340 $582,000

Others Institutions Holding MYGN

About MYRIAD GENETICS INC


  • Ticker MYGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 80,634,800
  • Market Cap $1.77B
  • Description
  • Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...
More about MYGN
Track This Portfolio

Track Envestnet Asset Management Inc Portfolio

Follow Envestnet Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Envestnet Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Envestnet Asset Management Inc with notifications on news.